BPM's DNlite-IVD103 Secures MDA Approval in Malaysia

Bio Preventive Medicine Corp., an innovative professional in vitro diagnostic (IVD) manufacturer, announced today (31st) that DNlite-IVD103—the world's first diagnostic test designed to prevent the rapid progression of Diabetic Kidney Disease (DKD)—has successfully secured market authorization from the Medical Device Authority (MDA) of Malaysia. The company is currently aggressively establishing its sales and distribution channels across the Southeast Asian market.